EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Synergistic Strategy Combining Chemotherapy and Photodynamic Therapy to Eradicate Prostate Cancer

Aditi A Shirke iD, Ethan Walker iD, Sriprada Chavali, Gopalakrishnan Ramamurthy iD, Lifang Zhang, Abhiram Panigrahi iD, James P Basilion iD, Xinning Wang iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Aditi A Shirke und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: Photochemotherapy, Prostatic Neoplasms, Photosensitizing Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institute of Health (NIH), National Foundation of Cancer Research (NFCR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer is the most prevalent cancer among men in the United States and is a leading cause of cancer-related death. Prostate specific membrane antigen (PSMA) has been established as a biomarker for prostate cancer diagnosis and treatment. This study aimed to develop a novel theranostic agent, PSMA-1-MMAE-Pc413, which integrates a PSMA-targeting ligand, the photosensitizer Pc413, and the microtubular inhibitor monomethyl auristatin E (MMAE) for synergistic therapeutic efficacy. In vitro uptake studies revealed that PSMA-1-MMAE-Pc413 demonstrated selective and specific uptake in PSMA-positive PC3pip cells but not in PSMA-negative PC3flu cells, with the uptake in PC3pip cells being approximately three times higher. In vitro cytotoxicity assays showed that, when exposed to light, PSMA-1-MMAE-Pc413 had a synergistic effect, leading to significantly greater cytotoxicity in PSMA-positive cells (IC50 = 2.2 nM) compared to PSMA-1-Pc413 with light irradiation (IC50 = 164.9 nM) or PSMA-1-MMAE-Pc413 without light irradiation (IC50 = 12.6 nM). In vivo imaging studies further demonstrated the selective uptake of PSMA-1-MMAE-Pc413 in PC3pip tumors. In in vivo studies, PSMA-1-MMAE-Pc413 dramatically improves the therapeutic outcome for prostate cancer by providing a synergistic effect that surpasses the efficacy of each treatment modality alone in PC3pip tumors. These findings suggest that PSMA-1-MMAE-Pc413 has strong potential for clinical application in improving prostate cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyProstatic NeoplasmsPhotosensitizing AgentsMaleHumansAnimalsCell Line, TumorMiceOligopeptidesXenograft Model Antitumor AssaysDrug SynergismGlutamate Carboxypeptidase IIAntigens, SurfaceAntineoplastic Agents

Stichwörter der Autor:innen

PSMAchemotherapycombination treatmentphotodynamic therapyprostate cancer

Substanzen

Photosensitizing AgentsOligopeptidesmonomethyl auristatin EGlutamate Carboxypeptidase IIAntigens, SurfaceFOLH1 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH 44106, USA.
  • Department of Biochemistry, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH 44106, USA.
  • Department of Radiology, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH 44106, USA.

ORCID-Profile: Aditi A Shirke, Ethan Walker, Gopalakrishnan Ramamurthy, Abhiram Panigrahi, James P Basilion, Xinning Wang

Förderung

  • NIH HHS
  • National Institute of Health (NIH)
  • National Foundation of Cancer Research (NFCR)

Zitieren

APA

Shirke, A. A., Walker, E., Chavali, S., Ramamurthy, G., Zhang, L., Panigrahi, A., Basilion, J. P., & Wang, X. (2024). A Synergistic Strategy Combining Chemotherapy and Photodynamic Therapy to Eradicate Prostate Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137086

Vancouver

Shirke AA, Walker E, Chavali S, Ramamurthy G, Zhang L, Panigrahi A, et al. A Synergistic Strategy Combining Chemotherapy and Photodynamic Therapy to Eradicate Prostate Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137086

BibTeX
@article{Shirke2024,
  author = {Shirke, Aditi A and Walker, Ethan and Chavali, Sriprada and Ramamurthy, Gopalakrishnan and Zhang, Lifang and Panigrahi, Abhiram and Basilion, James P and Wang, Xinning},
  title = {A Synergistic Strategy Combining Chemotherapy and Photodynamic Therapy to Eradicate Prostate Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137086}
}
Kostenlos starten →